Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAX2012Q in healthy adults 65-75 years
NCT02247362Phase 2Unknown
- Sponsor
- VaxInnate Corporation
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of VAX2012Q in influenza, sponsored by VaxInnate Corporation. Status: unknown.
02
Drugs
VAX2012Q
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02247362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247362.